| Reactivation of dormant relay pathways in injured spinal cord by KCC2 manipulations B Chen, Y Li, B Yu, Z Zhang, B Brommer, PR Williams, Y Liu, SV Hegarty, ... Cell 174 (3), 521-535. e13, 2018 | 241 | 2018 |
| Midbrain dopaminergic neurons: a review of the molecular circuitry that regulates their development SV Hegarty, AM Sullivan, GW O'keeffe Developmental biology 379 (2), 123-138, 2013 | 228 | 2013 |
| BMP-Smad 1/5/8 signalling in the development of the nervous system SV Hegarty, GW O’Keeffe, AM Sullivan Progress in neurobiology 109, 28-41, 2013 | 182 | 2013 |
| Zeb2: A multifunctional regulator of nervous system development SV Hegarty, AM Sullivan, GW O’Keeffe Progress in neurobiology 132, 81-95, 2015 | 107 | 2015 |
| Neurotrophic factors: from neurodevelopmental regulators to novel therapies for Parkinson's disease SV Hegarty, GW O’Keeffe, AM Sullivan Neural regeneration research 9 (19), 1708-1711, 2014 | 79 | 2014 |
| BMP2 and GDF5 induce neuronal differentiation through a Smad dependant pathway in a model of human midbrain dopaminergic neurons SV Hegarty, AM Sullivan, GW O'Keeffe Molecular and Cellular Neuroscience 56, 263-271, 2013 | 73 | 2013 |
| Canonical BMP–Smad signalling promotes neurite growth in rat midbrain dopaminergic neurons SV Hegarty, LM Collins, AM Gavin, SL Roche, SL Wyatt, AM Sullivan, ... Neuromolecular medicine 16, 473-489, 2014 | 63 | 2014 |
| Core transcription programs controlling injury-induced neurodegeneration of retinal ganglion cells F Tian, Y Cheng, S Zhou, Q Wang, A Monavarfeshani, K Gao, W Jiang, ... Neuron 110 (16), 2607-2624. e8, 2022 | 59 | 2022 |
| Roles for the TGFβ superfamily in the development and survival of midbrain dopaminergic neurons SV Hegarty, AM Sullivan, GW O’Keeffe Molecular neurobiology 50, 559-573, 2014 | 50 | 2014 |
| Exposure to hypertensive disorders of pregnancy increases the risk of autism spectrum disorder in affected offspring EA Curran, GW O’Keeffe, AM Looney, G Moloney, SV Hegarty, DM Murray, ... Molecular neurobiology 55, 5557-5564, 2018 | 49 | 2018 |
| Class-IIa histone deacetylase inhibition promotes the growth of neural processes and protects them against neurotoxic insult LM Collins, LJ Adriaanse, SD Theratile, SV Hegarty, AM Sullivan, ... Molecular neurobiology 51, 1432-1442, 2015 | 47 | 2015 |
| A small molecule activator of p300/CBP histone acetyltransferase promotes survival and neurite growth in a cellular model of Parkinson’s disease SV Hegarty, E O’Leary, F Solger, J Stanicka, AM Sullivan, GW O’Keeffe Neurotoxicity research 30, 510-520, 2016 | 42 | 2016 |
| The Epigenome as a therapeutic target for Parkinson's disease SV Hegarty, AM Sullivan, GW O'Keeffe Neural regeneration research 11 (11), 1735-1738, 2016 | 40 | 2016 |
| Effects of intracerebral neurotrophic factor application on motor symptoms in Parkinson's disease: a systematic review and meta-analysis SV Hegarty, DJ Lee, GW O'Keeffe, AM Sullivan Parkinsonism & related disorders 38, 19-25, 2017 | 34 | 2017 |
| Inhibition of miR-181a promotes midbrain neuronal growth through a Smad1/5-dependent mechanism: implications for Parkinson’s disease SV Hegarty, AM Sullivan, GW O’Keeffe Neuronal signaling 2 (1), NS20170181, 2018 | 28 | 2018 |
| Zeb2 is a negative regulator of midbrain dopaminergic axon growth and target innervation SV Hegarty, SL Wyatt, L Howard, E Stappers, D Huylebroeck, AM Sullivan, ... Scientific reports 7 (1), 8568, 2017 | 28 | 2017 |
| Viral vectors for neuronal cell type-specific visualization and manipulations Y Liu, S Hegarty, C Winter, F Wang, Z He Current opinion in neurobiology 63, 67-76, 2020 | 21 | 2020 |
| Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease GW O'Keeffe, SV Hegarty, AM Sullivan Neuronal Signaling 1 (2), NS20170027, 2017 | 18 | 2017 |
| Endocytosis contributes to BMP2-induced Smad signalling and neuronal growth SV Hegarty, AM Sullivan, GW O’Keeffe Neuroscience letters 643, 32-37, 2017 | 16 | 2017 |
| Romidepsin induces caspase-dependent cell death in human neuroblastoma cells SV Hegarty, KL Togher, E O’Leary, F Solger, AM Sullivan, GW O’Keeffe Neuroscience Letters 653, 12-18, 2017 | 13 | 2017 |
